
Fortis Healthcare: 7 Stock Signals Investors Are Watching Right Now
Fortis Healthcare CMP Rs 888.05. 52W range Rs 766.80-1,104.30. Mcap Rs 67,512 crore. PE 63.06 vs sector 68.95.
Updated: 23 Sept 2026 • 11:29 am
Posted by:

Quick Answer
Fortis Healthcare stock signals right now span an earnings picture, a shareholding pattern where promoter holding promoter and institutional shareholding figures were not available from the data source used here; investors can check the company's latest exchange filing directly, and a technical setup where the stock trades well off its 52-week low of Rs 766.80. Debt to equity stands at 0.35, and valuation sits at a P/E of 63.06 against a sector average of 68.95. Corporate developments in the integrated hospital and healthcare delivery services space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.
Fortis Healthcare stock signals are unusually layered right now, with the company trading at Rs 888.05, 19.6% below its 52-week high of Rs 1,104.30 and 15.8% above its 52-week low of Rs 766.80. Fortis Healthcare is a well tracked name in the integrated hospital and healthcare delivery services space, and no single headline captures where the stock stands today.
This article does not make a buy, hold or sell call on Fortis Healthcare. It lays out seven signals investors commonly watch, each sourced from the company's latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.
Click Here – Get Free Investment Predictions
Fortis Healthcare Stock at a Glance
Before going through each of the seven Fortis Healthcare stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.
| Metric | Value |
|---|---|
| Fortis Healthcare CMP | Rs 888.05 (NSE, 23 Sep 2026) |
| 52-Week High | Rs 1,104.30 (13 October 2025) |
| 52-Week Low | Rs 766.80 (30 March 2026) |
| Market Capitalisation | Rs 67,512 crore |
| P/E Ratio | 63.06 (Sector P/E 68.95) |
| P/B Ratio | 6.82 |
| Debt to Equity | 0.35 |
| Return on Equity | 10.53% |
1. Earnings Trend at Fortis Healthcare
Fortis Healthcare posted trailing-twelve-month revenue of Rs 9,556 crore versus Rs 9,178 crore a year earlier, while net profit moved to Rs 1,070 crore from Rs 1,064 crore, a change of 0.6% on the year. The most recent quarter added Rs 2,559.50 crore in revenue, a change of 17.3% year on year, against Rs 272.80 crore in net profit versus Rs 266.78 crore a year earlier.
net profit was up close to 2% year on year in the June 2026 quarter as revenue grew over 17%, though trailing-twelve-month profit growth is roughly flat versus a year earlier. This is the first of the seven Fortis Healthcare stock signals worth tracking closely into the next results.
2. FII Holding in Fortis Healthcare
A full quarterly FII holding series was not available from the data source used here for Fortis Healthcare. Where that is the case, the most reliable next step is to check the company's latest exchange filing directly, since a single-quarter snapshot can be misleading without the trend around it.
This is worth revisiting once the next quarterly shareholding disclosure is filed.
3. Promoter Holding in Fortis Healthcare
Promoter holding in Fortis Healthcare promoter and institutional shareholding figures were not available from the data source used here; investors can check the company's latest exchange filing directly.
This is worth revisiting once the next quarterly shareholding disclosure is filed, to see whether the level and direction of change persists.
4. Debt Position at Fortis Healthcare
Fortis Healthcare's debt to equity ratio stands at 0.35, one of the balance sheet metrics worth tracking alongside the earnings trend above. A lower or stable ratio generally gives more room to fund growth without leaning further on external borrowing, while a rising one is worth watching for its effect on finance costs.
This debt signal should be read alongside the valuation and corporate development signals below rather than in isolation, since capital raising plans can shift the picture from one quarter to the next.
5. Valuation of Fortis Healthcare Shares
At the current price, Fortis Healthcare trades at a price to earnings ratio of 63.06, a discount of close to 8.5% versus the sector average of 68.95. The price to book ratio stands at 6.82.
Whether that discount looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.
6. Technical Trend on the Fortis Healthcare Chart
The stock last traded around Rs 888.05, below its short-term average of about Rs 897.98, pointing to near-term weakness. The 14-day RSI reads close to 31, in neutral territory. The MACD line sits below its signal line, a bearish momentum bias.
Over the past year the stock is currently 19.6% below its 52-week high of Rs 1,104.30 and 15.8% above its 52-week low of Rs 766.80. A sustained move back above its recent average would be an early technical sign of stabilisation.
7. Corporate Developments at Fortis Healthcare
Fortis Healthcare operates 36 hospitals with close to 6,100 operational beds and over 400 diagnostics centres as of March 2026, and is adding more than 1,500 beds through brownfield expansion across its existing hospital network.
Check the Univest Screener for live fundamentals
What These Fortis Healthcare stock signals Mean Together
None of these seven signals on its own settles the debate on Fortis Healthcare. Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.
Investors weighing Fortis Healthcare would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in institutional positioning. Reading these Fortis Healthcare stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.
For context, investors following Fortis Healthcare often look at how the stock has moved through previous earnings cycles, how peer companies in the same space have reacted to similar corporate developments, and whether broader market conditions such as interest rate moves, sector-wide policy shifts or commodity price swings have played a larger role than company-specific news. None of these broader factors replace the seven signals above, but they help explain why a stock can move sharply even when no single company-specific trigger is visible in the data. Reading a stock's price action purely in isolation, without this wider lens, can lead to drawing conclusions that do not hold up once the next quarter's numbers or the next shareholding disclosure comes in. Investors are generally better served treating each of these seven factors as one input among several, updated on a rolling basis as new disclosures arrive, rather than as a one-time checklist filled in once and then set aside for the rest of the year without a further look.
Also Read: HDFC Bank: 7 Stock Signals Investors Are Watching Right Now
Conclusion
Fortis Healthcare currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Fortis Healthcare shares, and readers should form their own view based on their own research and risk appetite.
Download the Univest iOS App or Univest Android App to track Fortis Healthcare live price and more such signal based stock research.
Disclaimer: Data and figures in this article are sourced from publicly available information and the company's exchange filings. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Fortis Healthcare Stock Signals
Why is Fortis Healthcare share price where it is right now?
Ans. Fortis Healthcare shares are trading 19.6% below their 52-week high of Rs 1,104.30 and 15.8% above their 52-week low of Rs 766.80, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.
What is Fortis Healthcare's current FII holding?
Ans. A full quarterly FII holding series was not available for this article; check the company's latest exchange filing directly.
Is Fortis Healthcare's debt position a concern right now?
Ans. The debt to equity ratio stands at 0.35.
What is the promoter holding in Fortis Healthcare?
Ans. promoter and institutional shareholding figures were not available from the data source used here; investors can check the company's latest exchange filing directly.
Is Fortis Healthcare expensive compared to its sector?
Ans. Fortis Healthcare trades at a price to earnings ratio of 63.06 against a sector average of 68.95.
What recent corporate developments are relevant to Fortis Healthcare?
Ans. Fortis Healthcare operates 36 hospitals with close to 6,100 operational beds and over 400 diagnostics centres as of March 2026, and is adding more than 1,500 beds through brownfield expansion across its existing hospital network.
What do the technical charts suggest about Fortis Healthcare right now?
Ans. The stock is trading below its short-term average of about Rs 897.98, pointing to near-term weakness, with its MACD line below its signal line, a bearish momentum bias.
Should investors buy Fortis Healthcare shares at current levels?
Ans. This article does not offer a buy, hold or sell recommendation. It lays out seven Fortis Healthcare stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.
Recent Articles

Global Health: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

Laurus Labs: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

Krishna Institute of Medical Sciences: 7 Stock Signals Investors Are Watching Right Now
23 September 2026

IPCA Laboratories: 7 Stock Signals Investors Are Watching Right Now
23 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Global Health: 7 Stock Signals Investors Are Watching Right Now
Laurus Labs: 7 Stock Signals Investors Are Watching Right Now
Krishna Institute of Medical Sciences: 7 Stock Signals Investors Are Watching Right Now
IPCA Laboratories: 7 Stock Signals Investors Are Watching Right Now
Glenmark Pharmaceuticals: 7 Stock Signals Investors Are Watching Right Now
Popular this week
Gland Pharma: 7 Stock Signals Investors Are Watching Right Now

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





